Evidence map›Paper›PMID 23450047›Full record

ArticleThe Journal of clinical endocrinology and metabolism2013

Whole-exome sequencing studies of nonfunctioning pituitary adenomas.

Paul J Newey, M Andrew Nesbit, Andrew J Rimmer, Rosie A Head, Caroline M Gorvin, Moustafa Attar, Lorna Gregory, John A H Wass, David Buck, Niki Karavitaki and 4 more

Open access · bronzeAbstract readValidation Study
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 85 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Pituitary neuroendocrine tumors: a model for neuroendocrine tumor classification.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2021
    Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Paul J NeweyAcademic Endocrine Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7LJ, United Kingdom.
M Andrew Nesbit
Andrew J Rimmer
Rosie A Head
Caroline M Gorvin
Moustafa Attar
Lorna Gregory
John A H Wass
David Buck
Niki Karavitaki
Ashley B Grossman
Gilean McVean
Olaf Ansorge
Rajesh V Thakker
University of Oxford · GBGenomics (United Kingdom) · GBOxford University Hospitals NHS Trust · GBOxford Centre for Diabetes, Endocrinology and Metabolism · GB

Funding

Medical Research Council 91070Medical Research Council G1000467Medical Research Council G1000467/2010Medical Research Council G9825289/2004Wellcome Trust 090532Wellcome Trust 090532/Z/09/Z
6 · The paper itself

Abstract

contextThe tumorigenic role of genetic abnormalities in sporadic pituitary nonfunctioning adenomas (NFAs), which usually originate from gonadotroph cells, is unknown.

objectiveThe objective of the study was to identify somatic genetic abnormalities in sporadic pituitary NFAs.

designWhole-exome sequencing was performed using DNA from 7 pituitary NFAs and leukocyte samples obtained from the same patients. Somatic variants were confirmed by dideoxynucleotide sequencing, and candidate driver genes were assessed in an additional 24 pituitary NFAs.

resultsWhole-exome sequencing achieved a high degree of coverage such that approximately 97% of targeted bases were represented by more than 10 base reads; 24 somatic variants were identified and confirmed in the discovery set of 7 pituitary NFAs (mean 3.5 variants/tumor; range 1-7). Approximately 80% of variants occurred as missense single nucleotide variants and the remainder were synonymous changes or small frameshift deletions. Each of the 24 mutations occurred in independent genes with no recurrent mutations. Mutations were not observed in genes previously associated with pituitary tumorigenesis, although somatic variants in putative driver genes including platelet-derived growth factor D (PDGFD), N-myc down-regulated gene family member 4 (NDRG4), and Zipper sterile-α-motif kinase (ZAK) were identified; however, DNA sequence analysis of these in the validation set of 24 pituitary NFAs did not reveal any mutations indicating that these genes are unlikely to contribute significantly in the etiology of sporadic pituitary NFAs.

conclusionsPituitary NFAs harbor few somatic mutations consistent with their low proliferation rates and benign nature, but mechanisms other than somatic mutation are likely involved in the etiology of sporadic pituitary NFAs.

Indexed as

Sequence Analysis, DNAAdenomaAdultAgedAged, 80 and overDNA Mutational AnalysisExomeFemaleGene Expression Regulation, NeoplasticGenetic Association StudiesHumansMaleMicroarray AnalysisMiddle AgedMutationPituitary Neoplasms

Identifiers

PMID23450047
PMCPMC4447855
OpenAlexW2003401786

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.